NCT06585410 2026-04-22
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Recruiting
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Institut Claudius Regaud
Merck Sharp & Dohme LLC
NRG Oncology
Children's Oncology Group
Sun Yat-sen University